[August 1, 2023] FDA is warning consumers that two lots of Tydemy (drospirenone/ethinyl estradiol/levomefolate calcium), a prescription oral contraceptive (birth control pill) manufactured by Lupin Pharmaceuticals, may have reduced effectiveness due to decreased levels of ascorbic acid, an ingredient, in the product.
Enforcement Report - Week of June 14, 2023
Enforcement Report - Week Of June 01, 2022
Enforcement Report - Week of December 08, 2021
Health Canada Recalls CellChem Pharmaceuticals` Hot Lemon Relief For Symptoms of Cold and Flu (Acetaminophen 650mg, Phenylephrine Hydrochloride 10mg, Ascorbic Acid 50mg, Pheniramine Maleate 20mg)
KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
Enforcement Report - Week of August 14, 2019
British multinational drug major GlaxoSmithKline Pharmaceuticals has sold eight to 10 tail-end brands in 2018-19 (FY19), including its Vitamin C brand Celin and anti-infective brand Septran, as it focuses on paring down the number of brands in India to about 20 over the next one year. The firm’s FY19 annual report shows that it fetched Rs 5 crore during the year from the sale of brands.
Mary Kay Inc., a global cosmetics company and leader in skin care innovation, continues to support cosmetology and the scientific community through participation in two global dermatology conferences organized this spring. Mary Kay appeared on the prestigious Reunión Anual de Dermatólogos Latinoamericanos (RADLA) held from 4 to 7 May in Buenos Aires, Argentina, during which she presented the results on the impact of pollution on the condition of the skin. The company will also sponsor the 77th Annual Society for Investigative Dermatology (SID) in Chicago (May 8-11) and present the latest results of research on the beneficial effects on the skin's appearance of five extracts of fruits containing vitamin C.
Enforcement Report for Week of February 20, 2019